Hepatitis C News

Direct-acting antivirals first received approval for use in adults with hepatitis C in 2013. They were approved for use in children several years later, in 2017.

The COVID-19 pandemic has had “a tremendously negative impact” on efforts to eliminate hepatitis C, according to Ricardo Franco, MD.

Direct-acting antivirals for hepatitis C have not only led to a cure for the virus — they’ve also changed the paradigm in liver transplantation. This includes the transplantation of HCV-positive organs into HCV-negative recipients.

The CDC developed new recommendations for testing algorithms and clinical management of health care personnel with the possibility of occupational exposure to hepatitis C, according guidance from Morbidity and Mortality Weekly Report.

Among commercially insured patients in the United States, only 50% of those newly diagnosed with HIV underwent hepatitis C testing within 12 months of their diagnosis, according to data published in Open Forum Infectious Diseases.

In June, HHS and U.S. Public Health Service issued updated guidance on solid organ transplants to increase the number organs available for transplantation.

IDWeek organizers decided unanimously to convert this year’s meeting to a completely virtual event over concerns about COVID-19.

Donald Kaye, MD, MACP, an influential infectious diseases clinician and researcher and longtime Infectious Disease News Editorial Board Member, died July 4 at the age of 88, his family announced.

High rates of hepatitis C virus reinfection strongly correlated with risky sexual behavior among men who have sex with men who are HIV-positive, according to data published in Clinical Infectious Diseases.

Opioid agonist therapy can increase linkage to hepatitis C virus care among people who inject drugs, or PWID, according to a systematic review in Clinical Infectious Diseases.